{
    "N/R/U": null,
    "Applicant": "Alexion Pharmaceuticals, Inc.",
    "BLA Number": "761108",
    "Proprietary Name": "Ultomiris",
    "Proper Name": "ravulizumab-cwvz",
    "BLA Type": "351(a)",
    "Strength": "245MG/3.5ML (70MG/ML)",
    "Dosage Form": "Injection ",
    "Route of Administration": "Subcutaneous",
    "Product Presentation": "Single-Dose Cartridge",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "22-Jun-22",
    "Ref. Product Proper Name": null,
    "Ref. Product Proprietary Name": null,
    "Supplement Number": "21",
    "Submission Type": "Supplement",
    "License Number": "1743",
    "Product Number": "4",
    "Center": "CDER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": "7-Jun-28"
}